Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunwei Shen

Showing results (81-90 of 207) with videos related to

Pageof 21
Sort By:
Cancer Management and Research|August 19, 2021
Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant MetastasisYujie Lu, Yiwei Tong, Jiahui Huang, et al.
Journal of Translational Medicine|June 23, 2025
A pyrimidine metabolism-related gene signature for prognosis prediction and immune microenvironment description of breast cancerHan Wang, Ziling Zhou, Hanyi Zhong, et al.
Oncology Reports|June 13, 2014
A771726, an anti-inflammatory drug, exerts an anticancer effect and reverses tamoxifen resistance in endocrine-resistant breast cancer cellsOu Huang, Zuoquan Xie, Weili Zhang, et al.
BMC Medicine|July 10, 2026
Targeting ADGRG1 in cancer-associated adipocytes reprograms the immunosuppressive microenvironment and enhances immunotherapy responsiveness in triple-negative breast cancer modelsZiling Zhou, Hanyi Zhong, Han Wang, et al.
Japanese Journal of Clinical Oncology|September 14, 2013
Grb14 as an independent good prognosis factor for breast cancer patients treated with neoadjuvant chemotherapyOu Huang, Min Jiang, Xi Zhang, et al.
Molecules (Basel, Switzerland)|January 10, 2013
Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9Min Jiang, Ou Huang, Xi Zhang, et al.
Frontiers in Oncology|July 11, 2022
Association of Molecular Biomarker Heterogeneity With Treatment Pattern and Disease Outcomes in Multifocal or Multicentric Breast CancerShuai Li, Jiayi Wu, Ou Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2019
Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor SurgeryCaijin Lin, Jiayi Wu, Shuning Ding, et al.
International Journal of Biological Sciences|June 22, 2026
Cancer-associated adipocytes confer CDK4/6 inhibitor resistance in ER+ breast cancer through an IL-6/STAT3/SREBF2 axis coupled with cholesterol metabolism and cell cycle reprogrammingRenhong Huang, Yiwei Tong, Xi Sun, et al.
Frontiers in Oncology|June 2, 2020
Do 21-Gene Recurrence Score Influence Chemotherapy Decisions in T1bN0 Breast Cancer Patients?Jing Yu, Jiayi Wu, Ou Huang, et al.
Pageof 21

Showing results (81-90 of 207) with videos related to

Sort By:
Pageof 21
Cancer Management and Research|August 19, 2021
Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant MetastasisYujie Lu, Yiwei Tong, Jiahui Huang, et al.
Journal of Translational Medicine|June 23, 2025
A pyrimidine metabolism-related gene signature for prognosis prediction and immune microenvironment description of breast cancerHan Wang, Ziling Zhou, Hanyi Zhong, et al.
Oncology Reports|June 13, 2014
A771726, an anti-inflammatory drug, exerts an anticancer effect and reverses tamoxifen resistance in endocrine-resistant breast cancer cellsOu Huang, Zuoquan Xie, Weili Zhang, et al.
BMC Medicine|July 10, 2026
Targeting ADGRG1 in cancer-associated adipocytes reprograms the immunosuppressive microenvironment and enhances immunotherapy responsiveness in triple-negative breast cancer modelsZiling Zhou, Hanyi Zhong, Han Wang, et al.
Japanese Journal of Clinical Oncology|September 14, 2013
Grb14 as an independent good prognosis factor for breast cancer patients treated with neoadjuvant chemotherapyOu Huang, Min Jiang, Xi Zhang, et al.
Molecules (Basel, Switzerland)|January 10, 2013
Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogen-resistant breast cancer cell lines MCF-7/LCC2 and MCF-7/LCC9Min Jiang, Ou Huang, Xi Zhang, et al.
Frontiers in Oncology|July 11, 2022
Association of Molecular Biomarker Heterogeneity With Treatment Pattern and Disease Outcomes in Multifocal or Multicentric Breast CancerShuai Li, Jiayi Wu, Ou Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2019
Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor SurgeryCaijin Lin, Jiayi Wu, Shuning Ding, et al.
International Journal of Biological Sciences|June 22, 2026
Cancer-associated adipocytes confer CDK4/6 inhibitor resistance in ER+ breast cancer through an IL-6/STAT3/SREBF2 axis coupled with cholesterol metabolism and cell cycle reprogrammingRenhong Huang, Yiwei Tong, Xi Sun, et al.
Frontiers in Oncology|June 2, 2020
Do 21-Gene Recurrence Score Influence Chemotherapy Decisions in T1bN0 Breast Cancer Patients?Jing Yu, Jiayi Wu, Ou Huang, et al.
Pageof 21